• Mashup Score: 0

    The Association of American Medical Colleges estimates a shortage of as many as 139,000 physicians by 2033. ACR Workforce Solutions Committee Chair Daniel Battafarano, DO, outlined the types of projects committee members will undertake to improve the practice of rheumatology for providers and patients and combat the workforce shortage.

    Tweet Tweets with this article
    • #ACR22 Recap: ACR Workforce Solutions Committee members outlined the impact of physician shortages & explored potential interventions → https://t.co/TcgLVuURbu https://t.co/KGtofqU9Cy

  • Mashup Score: 0

    In 2022, the U.S. Food and Drug Administration approved the use of new agents for pediatric lupus nephritis, juvenile psoriatic arthritis, and enthesitis-related arthritis. Amit Golding, MD, PhD, highlighted the approvals of belimumab IV, ustekinumab, and secukinumab, and Cmdr. Hyun Son, PharmD, discussed the FDA’s role when drug shortages occur.

    Tweet Tweets with this article
    • #ACR22 Recap: FDA representatives gave an update on pediatric drug shortages, new approvals, & biosimilars → https://t.co/o7b2KzIcHO https://t.co/gnyIvG22R2